技术资料
-
文献De Giorgi U et al. (MAY 2011) Cancer biology & therapy 11 9 812--5Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.
Purpose: The bone marrow microenvironment is considered a critical component in the dissemination and fate of cancer cells in the metastatic process. We explored the possible correlation between bone marrow mesenchymal stem cells (BM-MSC) and disseminated breast cancer-initiating cells (BCIC) in primary breast cancer patients. Experimental design: Bone marrow mononuclear cells (BM-MNC) were collected at the time of primary surgery in 12 breast cancer patients. BM-MNC was immunophenotyped and BCIC was defined as epithelial cells (CD326+CD45-) with a stem-like" phenotype (CD44+CD24low/-� View Publication -
文献Liu S et al. (JAN 2011) Cancer research 71 2 614--24Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.
We have used in vitro and mouse xenograft models to examine the interaction between breast cancer stem cells (CSC) and bone marrow-derived mesenchymal stem cells (MSC). We show that both of these cell populations are organized in a cellular hierarchy in which primitive aldehyde dehydrogenase expressing mesenchymal cells regulate breast CSCs through cytokine loops involving IL6 and CXCL7. In NOD/SCID mice,labeled MSCs introduced into the tibia traffic to sites of growing breast tumor xenografts where they accelerated tumor growth by increasing the breast CSC population. With immunochemistry,we identified MSC-CSC niches in these tumor xenografts as well as in frozen sections from primary human breast cancers. Bone marrow-derived MSCs may accelerate human breast tumor growth by generating cytokine networks that regulate the CSC population. View Publication -
文献Diehn M et al. (APR 2009) Nature 458 7239 780--3Association of reactive oxygen species levels and radioresistance in cancer stem cells.
The metabolism of oxygen,although central to life,produces reactive oxygen species (ROS) that have been implicated in processes as diverse as cancer,cardiovascular disease and ageing. It has recently been shown that central nervous system stem cells and haematopoietic stem cells and early progenitors contain lower levels of ROS than their more mature progeny,and that these differences are critical for maintaining stem cell function. We proposed that epithelial tissue stem cells and their cancer stem cell (CSC) counterparts may also share this property. Here we show that normal mammary epithelial stem cells contain lower concentrations of ROS than their more mature progeny cells. Notably,subsets of CSCs in some human and murine breast tumours contain lower ROS levels than corresponding non-tumorigenic cells (NTCs). Consistent with ROS being critical mediators of ionizing-radiation-induced cell killing,CSCs in these tumours develop less DNA damage and are preferentially spared after irradiation compared to NTCs. Lower ROS levels in CSCs are associated with increased expression of free radical scavenging systems. Pharmacological depletion of ROS scavengers in CSCs markedly decreases their clonogenicity and results in radiosensitization. These results indicate that,similar to normal tissue stem cells,subsets of CSCs in some tumours contain lower ROS levels and enhanced ROS defences compared to their non-tumorigenic progeny,which may contribute to tumour radioresistance. View Publication -
文献Eirew P et al. (DEC 2008) Nature medicine 14 12 1384--9A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability.
Previous studies have demonstrated that normal mouse mammary tissue contains a rare subset of mammary stem cells. We now describe a method for detecting an analogous subpopulation in normal human mammary tissue. Dissociated cells are suspended with fibroblasts in collagen gels,which are then implanted under the kidney capsule of hormone-treated immunodeficient mice. After 2-8 weeks,the gels contain bilayered mammary epithelial structures,including luminal and myoepithelial cells,their in vitro clonogenic progenitors and cells that produce similar structures in secondary transplants. The regenerated clonogenic progenitors provide an objective indicator of input mammary stem cell activity and allow the frequency and phenotype of these human mammary stem cells to be determined by limiting-dilution analysis. This new assay procedure sets the stage for investigations of mechanisms regulating normal human mammary stem cells (and possibly stem cells in other tissues) and their relationship to human cancer stem cell populations. View Publication -
文献Raouf A et al. (JUL 2008) Cell stem cell 3 1 109--18Transcriptome analysis of the normal human mammary cell commitment and differentiation process.
Mature mammary epithelial cells are generated from undifferentiated precursors through a hierarchical process,but the molecular mechanisms involved,particularly in the human mammary gland,are poorly understood. To address this issue,we isolated highly purified subpopulations of primitive bipotent and committed luminal progenitor cells as well as mature luminal and myoepithelial cells from normal human mammary tissue and compared their transcriptomes obtained using three different methods. Elements unique to each subset of mammary cells were identified,and changes that accompany their differentiation in vivo were shown to be recapitulated in vitro. These include a stage-specific change in NOTCH pathway gene expression during the commitment of bipotent progenitors to the luminal lineage. Functional studies further showed NOTCH3 signaling to be critical for this differentiation event to occur in vitro. Taken together,these findings provide an initial foundation for future delineation of mechanisms that perturb primitive human mammary cell growth and differentiation. View Publication -
文献Lindvall C et al. (NOV 2006) The Journal of biological chemistry 281 46 35081--7The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.
Canonical Wnt signaling has emerged as a critical regulatory pathway for stem cells. The association between ectopic activation of Wnt signaling and many different types of human cancer suggests that Wnt ligands can initiate tumor formation through altered regulation of stem cell populations. Here we have shown that mice deficient for the Wnt co-receptor Lrp5 are resistant to Wnt1-induced mammary tumors,which have been shown to be derived from the mammary stem/progenitor cell population. These mice exhibit a profound delay in tumorigenesis that is associated with reduced Wnt1-induced accumulation of mammary progenitor cells. In addition to the tumor resistance phenotype,loss of Lrp5 delays normal mammary development. The ductal trees of 5-week-old Lrp5-/- females have fewer terminal end buds,which are structures critical for juvenile ductal extension presumed to be rich in stem/progenitor cells. Consequently,the mature ductal tree is hypomorphic and does not completely fill the fat pad. Furthermore,Lrp5-/- ductal cells from mature females exhibit little to no stem cell activity in limiting dilution transplants. Finally,we have shown that Lrp5-/- embryos exhibit substantially impaired canonical Wnt signaling in the primitive stem cell compartment of the mammary placodes. These findings suggest that Lrp5-mediated canonical signaling is required for mammary ductal stem cell activity and for tumor development in response to oncogenic Wnt effectors. View Publication
过滤器
筛选结果
研究领域
- HIV 85 项目
- HLA 60 项目
- 上皮细胞生物学 223 项目
- 上皮细胞研究 50 项目
- 免疫 1023 项目
- 内皮细胞研究 3 项目
- 呼吸系统研究 37 项目
- 嵌合体 30 项目
- 干细胞生物学 2916 项目
- 感染性疾病(传染病) 19 项目
- 抗体制备 6 项目
- 新陈代谢 4 项目
- 杂交瘤制备 3 项目
- 疾病建模 209 项目
- 癌症 31 项目
- 神经科学 665 项目
- 移植研究 104 项目
- 类器官 156 项目
- 细胞外囊泡研究 8 项目
- 细胞治疗开发 67 项目
- 细胞疗法开发 52 项目
- 细胞系制备 187 项目
- 脐带血库 72 项目
- 药物发现和毒理检测 380 项目
- 血管生成细胞研究 2 项目
- 传染病 32 项目
- 内皮细胞生物学 6 项目
- 杂交瘤生成 18 项目
- 癌症研究 677 项目
- 血管生成细胞研究 56 项目
Show More
Show Less
产品系列
- ALDEFLUOR 2 项目
- EpiCult 4 项目
Show More
Show Less
细胞类型
- B 细胞 236 项目
- CD4+ 57 项目
- CD8+ 43 项目
- CHO细胞 19 项目
- HEK-293细胞(人胚肾293细胞) 2 项目
- HUVEC细胞(人脐静脉内皮细胞) 1 项目
- NK 细胞 175 项目
- PSC衍生 89 项目
- T 细胞 445 项目
- 上皮细胞 135 项目
- 中胚层 9 项目
- 乳腺细胞 102 项目
- 先天性淋巴细胞 41 项目
- 全血 8 项目
- 其他子集 8 项目
- 其他细胞系 9 项目
- 内皮细胞 19 项目
- 内皮集落形成细胞(ECFCs) 3 项目
- 内胚层 9 项目
- 前列腺细胞 19 项目
- 单个核细胞 78 项目
- 单核细胞 175 项目
- 多巴胺能神经元 1 项目
- 多能干细胞 1983 项目
- 小胶质细胞 4 项目
- 巨噬细胞 36 项目
- 巨核细胞 10 项目
- 心肌细胞 28 项目
- 成骨细胞 9 项目
- 星形胶质细胞 7 项目
- 杂交瘤细胞 97 项目
- 树突状细胞(DCs) 132 项目
- 气道细胞 17 项目
- 淋巴细胞 84 项目
- 癌细胞及细胞系 144 项目
- 癌细胞和细胞系 3 项目
- 白细胞 16 项目
- 白细胞单采样本 12 项目
- 白血病/淋巴瘤细胞 14 项目
- 监管 8 项目
- 真皮细胞 2 项目
- 神经元 13 项目
- 神经干/祖细胞 472 项目
- 神经细胞 41 项目
- 粒细胞及其亚群 106 项目
- 红系细胞 12 项目
- 红细胞 12 项目
- 肌源干/祖细胞 10 项目
- 肝细胞 41 项目
- 肠道细胞 89 项目
- 肾细胞 6 项目
- 肿瘤细胞 25 项目
- 胰腺细胞 16 项目
- 脂肪细胞 6 项目
- 脑肿瘤干细胞 101 项目
- 血小板 4 项目
- 血浆 7 项目
- 血管生成细胞 4 项目
- 调节性细胞 11 项目
- 软骨细胞 8 项目
- 造血干/祖细胞 952 项目
- 造血干祖细胞 29 项目
- 造血细胞 15 项目
- 间充质基质细胞 20 项目
- 间充质干/祖细胞 204 项目
- 间充质干祖细胞 2 项目
- 间充质细胞 9 项目
- 骨髓基质细胞 1 项目
- 骨髓瘤细胞 2 项目
- 骨髓间质细胞 1 项目
- 髓系细胞 146 项目
- 肾脏细胞 3 项目
- CD4+T细胞 96 项目
- CD8+T细胞 75 项目
- PSC衍生上皮细胞 10 项目
- PSC衍生中胚层 16 项目
- PSC衍生内皮细胞 5 项目
- PSC衍生内胚层 14 项目
- PSC衍生心肌细胞 13 项目
- PSC衍生神经细胞 92 项目
- PSC衍生肝细胞 4 项目
- PSC衍生造血干细胞 14 项目
- PSC衍生间充质细胞 15 项目
- 其他T细胞亚型 18 项目
- 呼吸道细胞 75 项目
- 多巴胺能神经元 6 项目
- 小鼠胚胎成纤维细胞 1 项目
- 浆细胞 8 项目
- 神经元 183 项目
- 调节性T细胞 58 项目
- 骨髓瘤 3 项目
Show More
Show Less

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号